SECURITIES AND EXCHANGE COMMISSION
Washington, D. C. 20549
FORM 8-K
CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE
SECURITIES EXCHANGE ACT OF 1934
Date of Report (Date of earliest event reported): November 12, 2004
ACURA PHARMACEUTICALS, INC.
695 North Perryville Road, Rockford, Illinois 61107
(815-399-2060)
|
Incorporated under the laws of State of New York
|
Commission File Number
|
I.R.S. Employer Identification Number
|
|
|
1-10113
|
11-0853640
|
|
|
|
|
Item 2.02 Results of Operations and Financial Condition
On November 12, 2004, Acura Pharmaceuticals, Inc. (the "Company") issued a press release disclosing the financial results for its third quarter ended September 30, 2004 and the nine months ended September 30, 2004. A copy of the Company's press release is attached as Exhibit 99.1 hereto.
Item 9.01 Financial Statements and Exhibits.
| (b) Exhibits |
|
|
| |
|
|
|
| Exhibit Number |
|
Description |
| |
|
|
|
| 99.1 |
|
|
Press Release dated November 12, 2004 Announcing Results for Third Quarter ended September 30, 2004 |
| |
|
|
|
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.
| |
|
HALSEY DRUG CO., INC. |
|
| |
|
|
|
|
Date: November 15, 2004 |
|
By: /s/ Peter A. Clemens |
|
| |
|
Peter A. Clemens |
|
| |
|
Vice President & Chief Financial Officer |
|
| |
|
|
|
EXHIBIT INDEX
| |
|
|
|
| Exhibit Number |
|
Description |
| |
|
|
|
| 99.1 |
|
|
Press Release dated November 12, 2004 Announcing Results for Third Quarter ended September 30, 2004 |
| |
|
|
|